Article(id=1329914251315098346, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914192364154893, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.03.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1510848000000, receivedDateStr=2017-11-17, revisedDate=1515427200000, revisedDateStr=2018-01-09, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005866124, onlineDateStr=2026-11-18, pubDate=1520611200000, pubDateStr=2018-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005866124, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005866124, creator=13701087609, updateTime=1795005866124, updator=13701087609, issue=Issue{id=1329914192364154893, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='3', pageStart='S20', pageEnd='216', issueExtLink='null', onlineDate='null', pubDate='1520611200000', pubDateStr='2018-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005852069, creator='13701087609', updateTime=1795056602867, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330127057092195321, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914192364154893, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330127057092195322, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914192364154893, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=S20, endPage=S24, ext={EN=ArticleExt(id=1329914251529007851, articleId=1329914251315098346, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Clinical application of sevelamer carbonate in the treatment of chronic kidney disease with mineral and bone disorder, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the serious complications of long-term dialysis patients, which not only affects the life quality of dialysis patients, but also increases the death risk of dialysis patients. The existing research supports that the hyperphosphatemia is the initiating factor of CKD-MBD. Effective control of serum phosphorus level can improve patients' life quality and their prognosis. Sevelamer carbonate is a new type of phosphate binder, which has the exact effect and less side effects compared with the calcium-based phosphate binders. It has been proved to have other more benefits than reducing phosphorus. This paper reviews the clinical application of sevelamer carbonate in the treatment of CKD-MBD.
, authors=Shan-shan GUO, Yu-zhu WANG
*, authorsList=Shan-shan GUO, Yu-zhu WANG, authorCompany=null, correspAuthors=Yu-zhu WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914251810026220, articleId=1329914251315098346, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=碳酸司维拉姆治疗慢性肾脏病矿物质、骨代谢异常的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
随着透析质量的提高,透析龄的延长,透析慢性并发症引起关注。慢性肾脏病矿物质、骨代谢异常(CKD-MBD)是长期透析患者的严重并发症之一,影响透析患者的生活质量,更增加透析患者的死亡风险。高磷血症是CKD-MBD的始动因素,新型降磷药物碳酸司维拉姆,可有效控制血磷水平,提高透析患者的生存质量,不良反应较少,并有降血磷之外的益处,本文综述碳酸司维拉姆治疗CKD-MBD患者的临床应用研究进展。
, authors=郭姗姗, 王玉柱
*, authorsList=郭姗姗, 王玉柱, authorCompany=null, correspAuthors=王玉柱, authorNote=
郭姗姗,主治医师,研究方向:肾脏替代治疗患者一体化管理,特别是腹膜透析患者的随访管理。
, correspAuthorsNote=
王玉柱,主任医师,教授,硕士研究生导师,研究方向:血液透析及复杂血管通路的制作与维护,血管通路并发症的手术及介入治疗。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=pdDiVjsOJRCI4oJ90hl3VQ==, magXml=4jSu2hmmTHyoWgw6Nt4aMg==, pdfUrl=null, pdf=wgVWvu1hmL4fXJbuYRnkYg==, pdfFileSize=819710, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=oRb9Ip8cl91aw2BilGIhaw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914315924156838, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914316012237224, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, authorId=1329914315924156838, language=EN, stringName=Shan-shan GUO, firstName=Shan-shan, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing 100080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914316091929001, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, authorId=1329914315924156838, language=CN, stringName=郭姗姗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京市海淀医院,北京大学第三医院海淀院区肾脏内科,北京 100080, bio={"content":"
郭姗姗,主治医师,研究方向:肾脏替代治疗患者一体化管理,特别是腹膜透析患者的随访管理。
"}, bioImg=null, bioContent=
郭姗姗,主治医师,研究方向:肾脏替代治疗患者一体化管理,特别是腹膜透析患者的随访管理。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914315823493538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, xref=null, ext=[AuthorCompanyExt(id=1329914315836076451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing 100080, China), AuthorCompanyExt(id=1329914315844465060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京市海淀医院,北京大学第三医院海淀院区肾脏内科,北京 100080)])]), Author(id=1329914316159037867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914316238729645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, authorId=1329914316159037867, language=EN, stringName=Yu-zhu WANG, firstName=Yu-zhu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=Department of Nephrology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing 100080, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914316297449902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, authorId=1329914316159037867, language=CN, stringName=王玉柱, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=北京市海淀医院,北京大学第三医院海淀院区肾脏内科,北京 100080, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914315823493538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, xref=null, ext=[AuthorCompanyExt(id=1329914315836076451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing 100080, China), AuthorCompanyExt(id=1329914315844465060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京市海淀医院,北京大学第三医院海淀院区肾脏内科,北京 100080)])])], keywords=[Keyword(id=1329914316419084719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=EN, orderNo=1, keyword=sevelamer carbonate), Keyword(id=1329914316477804976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=EN, orderNo=2, keyword=hyperphosphatemia), Keyword(id=1329914316540719537, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=EN, orderNo=3, keyword=dialysis), Keyword(id=1329914316595245490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=CN, orderNo=1, keyword=碳酸司维拉姆), Keyword(id=1329914316670742963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=CN, orderNo=2, keyword=高磷血症), Keyword(id=1329914316721074612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, language=CN, orderNo=3, keyword=透析)], refs=[Reference(id=1329914316872069557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang L, Wang F, Wang L,
et al. Prevalence of chronic kidney disease in China: across-sectional survey[J]. Lancet, 2012, 379(9818): 815-822., articleTitle=null, refAbstract=null), Reference(id=1329914316934984118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Kong X, Zhang L Chen N,
et al. Mineral and bone disorder in chinese dialysis patients: a multicenter study[J]. Bio Med Central Nephrol, 2012, 13(9): 116-116., articleTitle=null, refAbstract=null), Reference(id=1329914316993704375, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Palmer SC, Hsayen A, Macaskill P,
et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risk of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis[J]. J Am Med Assoc, 2011, 305(11): 1119-1127., articleTitle=null, refAbstract=null), Reference(id=1329914317052424632, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Danese MD, Belozeroff V, Smirnakis K,
et al. Consistent control of mineral and bone disorder in incident hemodialysis patients[J]. Clin J Am Soc Nephrol, 2008, 3(5): 1423-1429., articleTitle=null, refAbstract=null), Reference(id=1329914317123727801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen N, Wu X, Ding X,
et al. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study[J]. Nephrol Dial Transplant, 2014, 29(1): 152-160., articleTitle=null, refAbstract=null), Reference(id=1329914317182448058, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Patel L, Bernard LM, Elder GJ. Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials[J]. Clin J Am Soc Nephrol, 2016, 11(2): 232-244., articleTitle=null, refAbstract=null), Reference(id=1329914317253751227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Block GA, Spiegel DM, Ehrlich J,
et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis[J]. Kidney Int, 2005, 68(4): 1815-1824., articleTitle=null, refAbstract=null), Reference(id=1329914317316665788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Block GA, Raggi P, Bellasi A,
et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients[J]. Kidney Int, 2007, 71(5): 438-441., articleTitle=null, refAbstract=null), Reference(id=1329914317408940477, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Di Iorio B, Molony D, Bell C,
et al. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial[J]. Am J Kidney Dis, 2013, 62(4): 771-778., articleTitle=null, refAbstract=null), Reference(id=1329914317488632254, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients[J]. Kidney Int, 2002, 62(1): 245-252., articleTitle=null, refAbstract=null), Reference(id=1329914317559935423, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Chertow GM, Raggi P, Chasan-Taber S,
et al. Determinants of progressive vascular calcification in haemodialysis patients[J]. Nephrol Dial Transplant, 2004, 19(6): 1489-1496., articleTitle=null, refAbstract=null), Reference(id=1329914317622849984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Di Iorio B, Bellasi A, Russo D. Mortality in kidney disease patients treated with phosphate binders: a randomized study[J]. Clin J Am Soc Nephrol, 2012, 7(3): 487-493., articleTitle=null, refAbstract=null), Reference(id=1329914317706736065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Sekercioglu N, Angeliki Veroniki A, Thabane L,
et al. Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: a systematic review and NMA[J]. PLoS One, 2017, 12(3): e0171028-e0171028., articleTitle=null, refAbstract=null), Reference(id=1329914317773844930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Qunibi W, Moustafa M, Muenz LR,
et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the calcium acetate renagel evaluation-2 (CARE-2) study[J]. Am J Kidney Dis, 2008, 51(6): 952-965., articleTitle=null, refAbstract=null), Reference(id=1329914317840953795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease[J]. Semin Dial, 2007, 20(4): 302-308., articleTitle=null, refAbstract=null), Reference(id=1329914317933228484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Faul C, Amaral AP, Oskouei B,
et al. FGF23 induces left ventricular hypertrophy[J]. J Clin Invest, 2011, 121(11): 4393-4408., articleTitle=null, refAbstract=null), Reference(id=1329914318004531653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Gutiérrez OM, Mannstadt M, Isakova T,
et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis[J]. N Engl J Med, 2008, 359(7): 584-592., articleTitle=null, refAbstract=null), Reference(id=1329914318121972166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Kendrick J, Cheung AK, Kaufman JS,
et al. FGF-23 associates with death, cardiovascular events and dialysis initiation[J]. J Am Soc Nephrol, 2011, 22(10): 1913-1922., articleTitle=null, refAbstract=null), Reference(id=1329914318184886727, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Gutiérrez OM, Januzzi JL, Isakova T,
et al. Fibroblast growth factor-23 and left ventricular hypertrophy in chronic kidney disease[J]. Circulation, 2009, 119(19): 2545-2552., articleTitle=null, refAbstract=null), Reference(id=1329914318251995592, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Sharma S, Joseph J, Chonchol M,
et al. Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients[J]. Clin Nephrol, 2013, 80(5): 313-321., articleTitle=null, refAbstract=null), Reference(id=1329914318319104457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Yilmaz MI, Sonmez A, Saglam M,
et al. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial[J]. Am J Kidney Dis, 2012, 59(2): 177-185., articleTitle=null, refAbstract=null), Reference(id=1329914318373630410, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin HH, Liou HH, Wu MS,
et al. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients[J]. Nephrology (Carlton), 2014, 19(11): 672-678., articleTitle=null, refAbstract=null), Reference(id=1329914318423962059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Garg JP, Chasan-Taber S, Blair A,
et al. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial[J]. Arthritis Rheum, 2005, 52(1): 290-295., articleTitle=null, refAbstract=null), Reference(id=1329914318474293708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Guida B, Cataldi M, Riccio E,
et al. Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a cross-sectional observational study[J]. PLoS One, 2013, 8(8): e73558-e73558., articleTitle=null, refAbstract=null), Reference(id=1329914318533013965, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Ferramosca E, Burke S, Chasan-Taber S,
et al. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients[J]. Am Heart J, 2005, 149(5): 820-825., articleTitle=null, refAbstract=null), Reference(id=1329914318587539918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Navarro-Gonza´lez JF, Mora-Ferna´ndez C, Muros de Fuentes M,
et al. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2011, 6(9): 2272-2279., articleTitle=null, refAbstract=null), Reference(id=1329914318654648783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Caglar K, Yilmaz MI, Saglam M,
et al. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients[J]. Clin J Am Soc Nephrol, 2008, 3(1): 61-68., articleTitle=null, refAbstract=null), Reference(id=1329914318742729168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Shantouf R, Budoff MJ, Ahmadi N,
et al. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients[J]. Am J Nephrol, 2008, 28(2): 275-279., articleTitle=null, refAbstract=null), Reference(id=1329914318814032337, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Vlassara H, Uribarri J, Cai W,
et al. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease[J]. Clin J Am Soc Nephrol, 2012, 7(6): 934-942., articleTitle=null, refAbstract=null), Reference(id=1329914318876946898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Cai W, Ramdas M, Zhu L,
et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1[J]. Proc Natl Acad Sci USA, 2012, 109(39): 15888-15893., articleTitle=null, refAbstract=null), Reference(id=1329914318944055763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Vlassara H, Uribarri J, Cai W,
et al. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease[J]. Clin J Am Soc Nephrol, 2012, 7(6): 934-942., articleTitle=null, refAbstract=null), Reference(id=1329914319006970324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Yubero-Serrano EM, Woodward M, Poretsky L,
et al. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease[J]. Clin J Am Soc Nephrol, 2015, 10(5): 759-766., articleTitle=null, refAbstract=null), Reference(id=1329914319074079189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=魏青, 刘宏, 汤日宁, 等. 司维拉姆对血液透析患者疗效和终点事件影响的荟萃分析[J]. 临床荟萃, 2015, 30(9): 1008-1012., articleTitle=null, refAbstract=null), Reference(id=1329914319157965270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Fan S, Ross C, Mitra S,
et al. A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis[J]. Nephrol Dial Transplant, 2009, 24(12): 3794-3799., articleTitle=null, refAbstract=null), Reference(id=1329914319220879831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Takagi K, Masuda K, Yamazaki M,
et al. Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins[J]. Clin Nephrol, 2010, 73(1): 30-35., articleTitle=null, refAbstract=null), Reference(id=1329914319279600088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Pierce D, Hossack S, Poole L,
et al. The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol[J]. Nephrol Dial Transplant, 2011, 26(5): 1615-1621., articleTitle=null, refAbstract=null), Reference(id=1329914319342514649, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamaguchi T, Ohyama S, Furukawa H,
et al. Sigmoid colon diverticula perforation associated with sevelamer hydrochloride administration: a case report[J]. Ann Med Surg (Lond), 2016, 10(8): 57-60., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914315823493538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, xref=null, ext=[AuthorCompanyExt(id=1329914315836076451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital, Beijing 100080, China), AuthorCompanyExt(id=1329914315844465060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914251315098346, companyId=1329914315823493538, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京市海淀医院,北京大学第三医院海淀院区肾脏内科,北京 100080)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.03.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.03.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.03.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.03.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1520611200000, fullTextJson=null, articleText=null, reference=null)